[Haemophilus influenzae type b infections in children].
Neijens
H J
HJ
Afd. Kindergeneeskunde, Academisch Ziekenhuis Rotterdam-Sophia Kinderziekenhuis.
de Groot
R
R
Dzoljic-Danilovic
G
G
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D001170:Arthritis, Infectious / Q000382:microbiology; D016667:Bacterial Capsules; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002481:Cellulitis / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D004826:Epiglottitis / Q000382:microbiology; D006192:Haemophilus Infections / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D008583:Meningitis, Haemophilus / Q000503:physiopathology; D011135:Polysaccharides, Bacterial / Q000276:immunology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D011135:Polysaccharides, Bacterial